Rapid-acting insulin analogs--its biological characteristics and clinical availability
Yokono, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 60(Suppl 9): 480-484
2002
ISSN/ISBN: 0047-1852 PMID: 12387038 Document Number: 550812
Document emailed within 1 workday
Related Documents
Yokono, K. 2001: Recent trends of development of rapid-acting and long-acting human insulin analogues--its biological characteristics and clinical availability Nihon Rinsho. Japanese Journal of Clinical Medicine 59(11): 2127-2133Hamaguchi, T.; Sadahiro, K.; Satoh, T. 2015: Current concept of insulin therapy intensification, and the role of human regular insulin and rapid-acting insulin analogs in insulin treatment Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 447-452
Matthaei, S.; Hamann, A. 1997: Current insulin therapy. Treatment with new short-acting and retard insulin analogs Fortschritte der Medizin 115(12): 35-6 39
Van Doorn, L.G. 1998: Fast-acting insulin analogs Nederlands Tijdschrift Voor Geneeskunde 142(20): 1165-1166
Wolffenbuttel, B.H.; Heine, R.J. 1998: Short-acting insulin analogs Nederlands Tijdschrift Voor Geneeskunde 142(8): 397-400
Holleman, F.; Hoekstra, J.B.L. 2004: Long-acting insulin analogs: progressing slowly Nederlands Tijdschrift Voor Geneeskunde 148(34): 1668-1669
Huvers, F. 2004: Long acting insulin analogs: possibly more stable glucose regulation Nederlands Tijdschrift Voor Geneeskunde 148(34): 1674-1678
Heise, T. 2007: Clinical therapeutics. Realising the value of modern insulins: reaching further with rapid-acting insulin analogues. XIX World Diabetes Congress, Cape Town, South Africa, December 3, 2006. Forward Clinical Therapeutics 29 Suppl D: S133-S134
2005: Advantages of fast-acting insulin analogs: preprandial greater HbA1c lowering -- postprandial lower weight MMWFortschrittederMedizin 147(33-34): 45
Benzi, L.; Marchetti, P.; Carriero, P.L.; Ciccarone, A.M.; Di Cianni, G.; Giannarelli, R.; Giovannitti, M.G.; Navalesi, R. 1987: Long-term therapy with biosynthetic human insulin: importance of short-acting/intermediate-acting insulin ratio on determining efficacy of treatment Drugs under Experimental and Clinical Research 13(5): 321-325
Stozek, T.; Krówczyński, L.; Bohdanowicz, T. 1983: Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations Acta Poloniae Pharmaceutica 40(1): 77-87
Shimoda, S.; Nishida, K.; Sakakida, M.; Konno, Y.; Ichinose, K.; Uehara, M.; Nowak, T.; Shichiri, M. 1997: Closed-loop subcutaneous insulin infusion algorithm with a short-acting insulin analog for long-term clinical application of a wearable artificial endocrine pancreas Frontiers of Medical and Biological Engineering: the International Journal of the Japan Society of Medical Electronics and Biological Engineering 8(3): 197-211
Jungmann, E. 1997: From human insulin to designer insulin. Why insulin analogs? Fortschritte der Medizin 115(12): 40-41
Lundershausen, R.; Potthoff, F.; Häuser, C.; Kaiser, M.; Münscher, C. 2006: Human insulin vs. analogs. What is the cost of supplementary insulin therapy? MMW Fortschritte der Medizin 148(45): 42
Nakazawa, T.; Chance, R.E. 1997: Basis for Insulin Lispro: physicochemical approach to fast-acting insulin analog Nihon Rinsho. Japanese Journal of Clinical Medicine 55 Suppl: 293-297
Kato, M. 1998: Biological and clinical analyses of the mechanism of growth retardation and the effect of recombinant human insulin-like growth factor-1 (rhIGF-1) treatment on glucose metabolism and growth in leprechaunism with severe insulin resistant diabetes Hokkaido Journal of Medical Science 73(6): 613-625
Dillingham, E.O.; Lasslo, A.; Gollamudi, R.; Bond, S.E.; Carter-Burks, G. 1990: The effect of carbamoylpiperidine and nipecotoylpiperazine analogs on ADP-stimulated human thrombocyte aggregation and platelet factor 3 availability Research Communications in Chemical Pathology and Pharmacology 67(2): 179-199
Morishita, H. 2015: Premixed insulin and intermediate-acting insulin Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 453-457
Havel, R.J. 1974: Lipid transport and the availability of insulin Hormone and Metabolic Research 4: 51-53
Lamberti, C.; Tarzia, I.; Mancini, F.; Di Benedetto, A.; De Leo, A.; Giunta, E.; Giannetti, C.; Cucinotta, D. 1985: Biological effects of 2 different types of human insulin and monocomponent porcine insulin in normal subjects Recenti Progressi in Medicina 76(11): 558-562